Titomic Limited (ASX: TTT), a global leader in cold spray additive manufacturing utilizing their Titomic Kinetic Fusion™ technology, is pleased to announce it has secured an Early Manufacturing ...
On December 15, 2025, Fahar Merchant, President and Chief Executive Officer of Medicenna Therapeutics Corp. ("Medicenna"), purchased an aggregate of 32,000 common shares of Medicenna (the "Shares") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback